Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Effects of ALZ-801, an Oral Amyloid Oligomer Inhibitor, on Biomarkers of Alzheimer’s Disease (AD): 12-Month Results of Phase 2 Biomarker Study in Early AD

              Author:Hey, John   Abushakra, Susan   Blennow, Kaj   Scheltens, Philip   Hort, Jakub   Sheardova, Katerina   Prins, Niels   Rutgers, Sterre   Dautzenberg, Paul   Pazdera, Ladislav   Kesslak, Patrick   Mandelbaum, Rosalind   Power, Aidan   Tolar, Martin   

              Session Name:S26: Experimental Therapeutics in Dementia  

              Topic:Aging and Dementia  

              Program Number:S26.007  

              Author Institution:Alzheon, Inc., Framingham, MA  Institute of Neuroscience & Physiology & Neurochemistry Laboratory, Molndal, Sweden  Amsterdam University Medical Centers, Amsterdam, Netherlands  Charles University Department of Neurology, Prague, Czech Republic  Memory Center, St. Anne University Hospital & International Clinical Research Center , Brno, Czech Republic  Brain Research Center, Amsterdam, Netherlands  Brain Research Center, Den Bosch, Netherlands  Vestra Research Clinics, Rychnov and Kneznou, Czech Republic